Clinical Trials in San Diego

Showing 3281-3300 of 14,679 trials

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

NCT05426174

This is a Phase I, first-in-human, randomized, modified double-blind, active-controlled, dose-escalation study to assess the safety and immunogenicity of up to 3 dose levels of mRNA NA vaccines, administered as a single IM injection in healthy adults aged 18 years and older. Two age groups, 18 to 64 years and ≥65 years, will be included in this study.

Influenza ImmunizationHealthy Volunteers

Sanofi Pasteur, a Sanofi Company233 participantsStarted Jun 2022

Huntsville, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +3 more locations

RECRUITING< 1 mile

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

NCT02523118

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.

Eosinophilic Gastrointestinal Disorders (EGIDs)Eosinophilic EsophagitisEosinophilic Gastritis+2 more

Children's Hospital Medical Center, Cincinnati1,350 participantsStarted Jul 2015

Phoenix, Arizona, United States • Rogers, Arkansas, United States • San Diego, California, United States +16 more locations

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Find Trials by Condition in San Diego

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System